PD L1 Inhibitors Market Is Anticipated To Reach USD 210.8 Billion, Grow at a CAGR Of 18.20 % From 2023 To 2032 PD L1 Inhibitors Market Research Report: Information By Type of Inhibitors (PD-1 Inhibitors and PD-L1 Inhibitors), By Application (Hodgkin Lymphoma, Kidney Cancer, Melanoma, Non-small Cell Lung Cancer and Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies